THERAPEUTIC DRUG MONITORING MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028)


Therapeutic Drug Monitoring Market Analysis:

The therapeutic drug monitoring market is projected to exhibit a compound annual growth rate (CAGR) of 7.5% over the forecast period. The global healthcare system faced significant challenges during the COVID-19 pandemic, with hospitals being understaffed and overburdened. The accurate and rapid diagnosis of SARS-CoV-2 infection was crucial, particularly for serological and immunological testing of asymptomatic and symptomatic individuals. Consequently, the pandemic had a profound impact on the market. According to a study published in Expert Review of Clinical Immunology in June 2021, enzyme-linked immunosorbent assays (ELISAs), chemiluminescent immunoassays (CLIAs), and lateral flow immunoassays (LFIAs) were the primary methodologies used for serology-based tests for detecting SARS-CoV-2. Additionally, a study titled “Rapid chromatographic immunoassay-based evaluation of COVID-19,” published in February 2021, found that rapid chromatographic immunoassay-based tests offered quick and accurate detection of COVID-19 with excellent specificity and moderate sensitivity. Although the market lost some traction as the pandemic subsided, it is expected to experience stable growth during the study’s forecast period.

Get the free sample report of the Therapeutic Drug Monitoring Market

Comments

Popular Posts

Aviation Industry Set to Soar: Market to Hit USD 395.76 Billion by 2030 Amid Stable Growth

Recreational Boating Market Set to Reach USD 36.82 Billion by 2030: Key Growth Drivers and Trends

Kuwait Dairy Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Coffee Machine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)